Europe’s medical devices industry saw a rise of 55% in cross border deal activity during January 2022, when compared with the last 12-month average, led by Ardian Holding’s $1.26bn private equity deal for 70% stake in Biofarma, according to GlobalData’s deals database.
A total of 31 medical devices industry cross border deals worth $1.7bn were announced for the region in January 2022, against the 12-month average of 20 deals.
Of all the deal types, M&A saw most activity in January 2022 with 14 transactions, representing a 45.2% share for the region.
